ArticleNature medicine2025
Author Correction: First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial.
Abstract readPublished Erratum
In one paragraph
Article in Nature medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum for
Authors and funding
90 authors.
Lin Shen *State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital & Institute, Beijing, China.ORCID http://orcid.org/0000-0003-1134-2922
Yanqiao Zhang *Harbin Medical University Cancer Hospital, Harbin, China.
Ziyu Li *Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Gastrointestinal Cancer Center, Peking University Cancer Hospital & Institute, Beijing, China.ORCID http://orcid.org/0000-0001-5580-4979
Xiaotian Zhang *State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital & Institute, Beijing, China.
Xiangyu Gao *State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital & Institute, Beijing, China.ORCID http://orcid.org/0000-0002-1697-1157
Bo LiuDepartment of Gastroenterology, Shandong Cancer Hospital, Jinan, China.
Yusheng WangShanxi Provincial Cancer Hospital, Taiyuan, China.
Yi BaTianjin Medical University Cancer Institute & Hospital, Tianjin, China.
Ning LiHenan Cancer Hospital, Zhengzhou, China.
Ruixing ZhangThe Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Jingdong ZhangLiaoning Cancer Hospital & Institute, Shenyang, China.
Ye ChenThe First Affiliated Hospital of Henan University of Science and Technology, Luoyang, China.
Jian ChenYantai Yuhuangding Hospital, Yantai, China.
Mingzhu HuangFudan University Shanghai Cancer Center, Shanghai, China.
Yang FuThe First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Mulin LiuThe First Affiliated Hospital of Bengbu Medical University, Bengbu, China.
Zheng LiuHandan Central Hospital, Handan, China.
Jun ZhaoChangzhi People's Hospital, Changzhi, China.
Wei LiThe First Bethune Hospital of Jilin University, Changchun, China.
Jia WeiNanjing Drum Tower Hospital, Nanjing, China.ORCID http://orcid.org/0000-0003-3024-8878
Changzheng LiDepartment of Gastroenterology, Shandong Cancer Hospital, Jinan, China.
Nong XuThe First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Zengqing GuoFujian Cancer Hospital, Fuzhou, China.
Bangwei CaoBeijing Friendship Hospital, Capital Medical University, Beijing, China.
Lian LiuQilu Hospital of Shandong University, Jinan, China.
Peng NieGansu Wuwei Tumour Hospital, Wuwei, China.
Lixin WanNanyang Central Hospital, Nanyang, China.
Lili ShengThe First Affiliated Hospital of Wannan Medical College, Wuhu, China.
Zhenyang LiuHunan Cancer Hospital, Changsha, China.
Yifu HeAnhui Provincial Cancer Hospital, Hefei, China.
Kangsheng GuThe First Affiliated Hospital of Anhui Medical University, Hefei, China.
Guowu WuMeizhou People's Hospital, Meizhou, China.
Weibo WangShandong Provincial Hospital, Jinan, China.
Futong ZhangShijiazhuang People's Hospital, Shijiazhuang, China.
Wensheng QiuThe Affiliated Hospital of Qingdao University, Qingdao, China.
Jun GuoXingtai People's Hospital, Xingtai, China.
Jieer YingZhejiang Cancer Hospital, Hangzhou, China.
Hongming PanSir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Huiting XuHubei Cancer Hospital, Wuhan, China.
Yuan YuanXuzhou Central Hospital, Xuzhou, China.
Yuansong BaiThe Third Bethune Hospital of Jilin University, Changchun, China.
Zhenghua WangThe First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.
Jiye XuZhoukou Central Hospital, Zhoukou, China.
Xuehong ZhaoLinfen Central Hospital, Linfen, China.
Hao LiuSichuan Provincial People's Hospital, Chengdu, China.
Xizhi ZhangNorthern Jiangsu People's Hospital, Yangzhou, China.
Wenxiang DaiThe First Affiliated Hospital of The University of South China, Hengyang, China.
Hongyan XuWeihai Municipal Hospital, Weihai, China.
Ming LiuWest China Hospital of Sichuan University, Chengdu, China.
Lin XieYunnan Cancer Hospital, Kunming, China.
Yong TangAffiliated Cancer Hospital of Xinjiang Medical University, Urumqi, China.
Jianying JinTaizhou Hospital of Zhejiang Province, Linhai, China.
Xiujuan QuThe First Hospital of China Medical University, Shenyang, China.
Xuefeng FangThe Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Mingwei HuangGuangxi Medical University Cancer Hospital, Nanning, China.
Hao ChenThe Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China.
Zhendong ZhengGeneral Hospital of Northern Theater Command, Shenyang, China.
Ying WangShengjing Hospital of China Medical University, Shenyang, China.
Daqing WangHengshui People's Hospital (Harrison International Peace Hospital), Hengshui, China.
Xiaoqin LiAffiliated Hospital of Jiangsu University, Zhenjiang, China.
Guohua YuWeifang People's Hospital, Weifang, China.
Haiyan LiuThe Second Affiliated Hospital of Shandong First Medical University, Tai'an, China.
Yongjian ZhouFujian Medical University Union Hospital, Fuzhou, China.
Diansheng ZhongTianjin Medical University General Hospital, Tianjin, China.
Shan ZengXiangya Hospital Central South University, Changsha, China.
Mafei KangAffiliated Hospital of Guilin Medical University, Guilin, China.
Meiqing WangHainan Cancer Hospital, Haikou, China.
Yong GaoHuai'an First People's Hospital, Huai'an, China.
Wenxin LiInner Mongolia Autonomous Region People's Hospital, Hohhot, China.
Zejun WangThe Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, China.
Minghui ZhangChifeng Municipal Hospital, Chifeng, China.
Jinghua ZhangCangzhou Central Hospital, Cangzhou, China.
Qingshan LiAffiliated Hospital of Chengde Medical University, Chengde, China.
Shujuan SunDaqing People's Hospital, Daqing, China.
Aimin ZangAffiliated Hospital of Hebei University, Baoding, China.
Lizhu LinThe First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Ming XieAffiliated Hospital of Zunyi Medical University, Zunyi, China.
Zhixiang ZhuangThe Second Affiliated Hospital of Soochow University, Suzhou, China.
Tao ZhangYuebei People's Hospital, Shaoguan, China.
Zhifang YaoAkeso Biopharma Inc., Zhongshan, China.
Dongmei LuAkeso Biopharma Inc., Zhongshan, China.
Wei LiuAkeso Biopharma Inc., Zhongshan, China.
Mingxiu HuAkeso Biopharma Inc., Zhongshan, China.
Zhongmin Maxwell WangAkeso Biopharma Inc., Zhongshan, China.ORCID http://orcid.org/0000-0002-1683-5147
Baiyong LiAkeso Biopharma Inc., Zhongshan, China.
Michelle XiaAkeso Biopharma Inc., Zhongshan, China.
Jiajia ZhangUniversity of California Los Angeles Health, Los Angeles, CA, USA.
Xiangji YingDepartment of Epidemiology, University of North Carolina Gillings School of Global Public Health, Chapel Hill, NC, USA.
Drew M PardollThe Bloomberg~Kimmel Institute for Cancer Immunotherapy and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID http://orcid.org/0000-0001-6215-1013
Jiafu JiState Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital & Institute, Beijing, China. jijiafu@hsc.pku.edu.cn.ORCID http://orcid.org/0000-0001-6878-5543
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
PMID
40140623What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.